Hepatocyte Specific Antigen antibody
Quick Overview for Hepatocyte Specific Antigen antibody (ABIN6937371)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Purified by Protein A/G
-
Immunogen
- Extract of a formalin-fixed, rejected-allograft of a human liver
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Positive Control: Liver or Hepatocellular Carcinoma (HCC).
Known Application: Immunofluorescence (0.5-1.0 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 10 mM PBS without BSA and without Azide.
-
Preservative
- Azide free
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months.
-
Expiry Date
- 24 months
-
-
- Hepatocyte Specific Antigen (HepPar-1)
-
Alternative Name
- Hepatocyte Specific Antigen (Hepatocellular Marker)
-
Background
- Hepatocyte Specific Antigen, also called Hepatocyte Paraffin 1 or HepPar1, localizes to the mitochondria of hepatocytes. It is a sensitive marker for distinguishing hepatocellular carcinomas (HCC) from other metastatic carcinomas as well as cholangio-carcinomas. HCC's occur primarily in the stomach, but they are also found in many other organs. The Hepatocyte Specific Antigen may also be a useful marker for intestinal metaplasia. Reportedly, strong expression of the Hepatocyte Specific Antigen correlates with smaller tumor size and longer patient survival. Occasionally, Hepatocyte Specific Antigen is also found in gastric carcinomas as well as in a few other non-hepatic tumors.
Target
-